Order or notice
DCGI circular on homoeopathic medicines containing phenolphthalein (Jul 2026)
Last checked 10 October 2026
On 6 Jul 2026 the Drugs Controller General of India told state drug controllers to stop the manufacture and sale of combinations containing phenolphthalein sold as homoeopathic medicines, because they do not meet the definition in Rule 2(dd) of the Drugs and Cosmetics Rules.
- Classification
- Manufacture halted by regulator direction (not a Section 26A ban)
- Decided by
- Drugs Controller General of India (CDSCO)
- Reference
- DCGI circular dated 6 Jul 2026, 'Manufacturing and marketing of Homoeopathic medicines containing Phenolphthalein'
- Latest action
- 6 July 2026
- Last checked
- 10 October 2026
Photo: An Ayurvedic Pharmacy, Rishikesh (1).jpg by Ken Wieland from Philadelphia, USA (CC BY-SA 2.0). All photo credits.
DCGI circular: Manufacturing and marketing of Homoeopathic medicines containing Phenolphthalein
Scope. A record here does not by itself mean a product or company is unsafe or banned today. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Below: Blacklisted's explanationWe organise and explain what the document says. The document above is the authority.
Key facts
- Date
- 6 Jul 2026
- Direction
- State drug controllers to stop manufacture and sale of the combinations
- Legal ground
- Combinations containing phenolphthalein do not meet the definition of a homoeopathic medicine in Rule 2(dd)
- Scope
- These combinations only; homoeopathic medicines in general are not affected
On 6 Jul 2026 the Drugs Controller General of India issued a circular, 'Manufacturing and marketing of Homoeopathic medicines containing Phenolphthalein'. It says combinations containing phenolphthalein do not meet the definition of a homoeopathic medicine in Rule 2(dd) of the Drugs and Cosmetics Rules, and tells state drug controllers to stop their manufacture and sale.
The circular is addressed to the states. We found no state seizure or licence action under it, and the text we read names no brand. It does not restrict homoeopathic medicines in general.
What this means for you
It is not a ban on homoeopathy
The circular concerns one ingredient in combinations. Other homoeopathic medicines are not mentioned.
Enforcement is by states
The circular is addressed to state drug controllers. Any seizure or licence action would come from them, and we have not found one.
This is a record of official orders, not medical advice. Do not stop a prescribed medicine without asking your doctor or pharmacist.
Common questions
Which brands are affected?
The circular text we read names no brand.
Official sources and primary records
- DCGI circular: Manufacturing and marketing of Homoeopathic medicines containing PhenolphthaleinRegulatorCDSCO · 6 July 2026
- Regulator